Legal Advantage Investments’s Merck MRK Stock Holding History

Legal Advantage Investments’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.17M	Buy	9,140 +100	+1%	+$11.7K	0.41%	48
2026 Q1	$1.09M	Hold	9,040	–	–	0.56%	46
2025 Q4	$952K	Hold	9,040	–	–	0.44%	54
2025 Q3	$759K	Hold	9,040	–	–	0.34%	64
2025 Q2	$716K	Buy	9,040 +5,040	+126%	+$401K	0.33%	66
2025 Q1	$359K	Hold	4,000	–	–	0.19%	82
2024 Q4	$398K	Hold	4,000	–	–	0.21%	83
2024 Q3	$454K	Hold	4,000	–	–	0.25%	77
2024 Q2	$495K	Hold	4,000	–	–	0.29%	73
2024 Q1	$528K	Hold	4,000	–	–	0.3%	73
2023 Q4	$436K	Hold	4,000	–	–	0.26%	74
2023 Q3	$412K	Hold	4,000	–	–	0.29%	69
2023 Q2	$462K	Hold	4,000	–	–	0.31%	72
2023 Q1	$426K	Hold	4,000	–	–	0.31%	70
2022 Q4	$444K	Hold	4,000	–	–	0.36%	62
2022 Q3	$344K	Hold	4,000	–	–	0.32%	66
2022 Q2	$365K	Hold	4,000	–	–	0.36%	58
2022 Q1	$328K	Hold	4,000	–	–	0.25%	66
2021 Q4	$307K	Buy	+4,000	New	+$319K	0.21%	71

Other funds holding MRK

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Legal Advantage Investments's MRK Position: Q2 2026 in Review

Legal Advantage Investments increased its Merck (MRK) stake by 1.1% in Q2 2026, buying an estimated $11.7K and bringing the position to 9,140 shares worth $1.17M. The position accounts for 0.41% of the portfolio, ranked #48.

Legal Advantage Investments first reported a position in MRK in Q4 2021 and has held it in 19 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Legal Advantage Investments held 9,140 shares of Merck worth $1.17M as of Q2 2026.
Legal Advantage Investments bought 100 Merck shares in Q2 2026, an estimated $11.7K.
Merck made up 0.41% of Legal Advantage Investments's portfolio in Q2 2026, its #48 holding.
Legal Advantage Investments first reported a position in Merck in Q4 2021 and has held it in 19 quarters since.
1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Legal Advantage Investments's 13F filing for Q2 2026, filed 15 Jul 2026.